![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |||
Founding Date | Founding Date 1929 | Founding Date 2003 | Founding Date 2017 | Founding Date 1935 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | |
Employees | Employees 5,358 | Employees 3,4721% increase | Employees 8007% increase | Employees 27,764 |
Financial | ||||
Revenue (est.) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) Kč2.3b (FY, 2021) | Revenue (est.) CHF220.6m (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods €659.1m (FY, 2025) | Cost of goods Kč807.2m (FY, 2021) | Cost of goods CHF20.9m (FY, 2025) | Cost of goods ₹97.2b (FY, 2026) |
Gross profit | Gross profit €3.3b (FY, 2025) | Gross profit Kč1.5b (FY, 2021) | Gross profit CHF214.3m (FY, 2025) | Gross profit ₹184.4b (FY, 2026) |
Net income | Net income €445.1m (FY, 2025) | Net income (Kč831.2m) (FY, 2021) | Net income (CHF111.7m) (FY, 2025) | Net income ₹38.7b (FY, 2026) |
Operating ⚠ | ||||
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 4 (Apr, 2023) | Manufacturing Sites N/A | Manufacturing Sites 46 (FY, 2024) |
Zentiva is a company that develops and manufactures generic medicines.
View company
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View company
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company